Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Aqua Metals Aqms Stock A Future Winner Price At 3.94 Up 0.25 20260410 Daily Market Overview Sp 500 Nasdaq Edge Up Dow Dips In Mixed Trade 20260403 1 Daily Market Overview Nasdaq Leads Dow S P 500 Higher In Todays Trade 20260409 1 Is Solstice Sols Stock Near A Bottom Price At 78.03 Up 2.11 20260406 Should I Sell Century Alum Cenx Stock Now Price At 62.70 Up 0.22 20260406 Auburn Banc AUBN Stock Research Q3 2024 Earnings Report CID HoldCo DAIC Stock Why Barrier to Entry Breakout Watch 20260416 CN Corp CZNC Stock Volume Leaders In Focus 20260418 ITHAX ITHA Stock Resistance Level Sideways 20260415 China Food Delivery Sector Regulatory Crackdown Ghost Vendor Scandal Triggers Record Fines and AntiInvolution Enforcement SNDR Schneider National shares gain 182 percent even after Q4 2025 EPS falls 37 percent short of analyst estimates Apple Inc AAPL Planned CEO Succession Aligns With Record Global CSuite Turnover Signals LongTerm Growth Catalyst Is Immunocore IMCR stock forming a continuation pattern Q4 2025 Earnings Fall Short Lam Research Corporation LRCX March 2026 Quarter Earnings Beat AIDriven Demand Lifts Near and LongTerm Growth Outlook The growth story Blue Water 3 BLUW is not telling investors RangeBound 20260508 AIB BlkDigInfra invests heavily in nextgen AI infrastructure to capture longterm industry growth opportunities GSA Goldman confirms steady floating rate preferred returns in its latest quarterly earnings release GGRP The reports wider than expected Q1 2026 per share loss stock dips modestly post earnings How Aspen Ins AHLF balances short term and long term focus Energy UUUU Slips 523 Testing 1756 Support 20260515 Gladstone GAIN Q1 2026 Earnings Miss EPS 020 vs 022 Expected Warren Buffett and Stephen Curry Charity Dinner Breaks Records with 9 Million Bid Forbes Opinion Government Boundaries Are Not Optional Private Business Shouldnt Enable Overreach Silicon SIMO Stock Slides 737 Support at 22880 20260518 Biofrontera BFRI Q1 2026 Earnings Miss Sparks Concern Captrust Expands Footprint With Acquisition of Pennsylvania Wealth Manager Stillwater Capital Advisors KKR Co KKR Q1 2026 Earnings Surprise EPS 139 Up Significant Louis Navellier Offers Blunt Assessment of Technology Stock Decline Tepid Demand at US Treasury Auction Reflects Geopolitical Concerns Over Iran Trump Medias Truth Social Withdraws Bitcoin ETF Application Implications for Crypto Markets Intuit Announces 17 Global Workforce Reduction in Streamlining Effort Berenbergs Chief Economist Warns ECB Rate Hikes Are a Big Mistake Amid Stagflation Fears Charter Communications Announces Improved Buyout Deal for Liberty Broadband Trump Postpones AI Executive Order Signing Citing Concerns Over Potential Regulatory Overreach Apimeds Posts 35M Q1 Deficit as Crypto Losses Weigh on Financials NYT Pips Hints and Answers Sunday May 24 Puzzle Walkthrough and Market Implications LivaNova LIVN Q1 2026 Earnings EPS Beats Estimates by 714 Amid Modest Stock Decline DPRO Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges Cheesecake Factory CAKE Q1 2026 Earnings Modest EPS Beat Lifts Shares Revenue Details Not Disclosed BioAge Labs Q1 2026 Earnings Narrower Loss Delivers Positive Surprise as PreRevenue Biotech Advances Pipeline STX Q1 2026 Earnings EPS Surges Past Estimates with Strong Operational Execution TransUnion TRU Gains Ground as Shares Approach Resistance MicroVision MVIS Surges 477 as Stock Tests Key Resistance Zone BATL Stock Plunges Over 10 Key Support at 161 in Focus Ameriprise Financial AMP Edges Higher as Support Holds Resistance Ahead Roblox Corporation RBLX Q1 2026 Earnings Surprise EPS 027 Up Significant Gloo Holdings GLOO Surges 200 Nearing 642 Resistance 20260518 Elon Musk Vows to Appeal After Jury Rules Against Him in OpenAI Trial Calls Verdict a Technicality Franklin FELE Q1 2026 Earnings Surprise EPS 083 Up Significant Ozari Health Launches Nationwide Telehealth Platform for Compounded GLP1 Therapies at 86 Per Month